Literature DB >> 6815281

A prospective microbiologic study of bacteriuria in patients with chronic indwelling urethral catheters.

J W Warren, J H Tenney, J M Hoopes, H L Muncie, W C Anthony.   

Abstract

Bacteriuria is common in chronically catheterized patients and is associated with both acute and chronic complications. Of 605 consecutive weekly urine specimens from 20 chronically catheterized patients, 98% contained bacteria at high concentrations and 77% were polymicrobial. The mean interval between new episodes of bacteriuria was 1.8 weeks. Most species of bacteria caused five to seven new episodes of bacteriuria per 100 weeks of catheterization. Even though access to the catheter lumen was similar, the duration of bacteriuric episodes varied greatly by species. Of the episodes of bacteriuria caused by nonenterococcal gram-positive cocci, greater than 75% lasted less than one week. Mean durations of episodes of bacteriuria due to Escherichia coli, Proteus mirabilis, and Pseudomonas aeruginosa were four to six weeks, whereas those due to Providencia stuartii averaged 10 weeks and ranged up to 36 weeks. Thus, the very high prevalence of bacteriuria--virtually 100%--was a result of a high incidence caused by many different species combined with the prolonged residence of some gram-negative bacilli in the catheter and urinary tract.

Entities:  

Mesh:

Year:  1982        PMID: 6815281     DOI: 10.1093/infdis/146.6.719

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  165 in total

1.  Activation of the 2'-N-acetyltransferase gene [aac(2')-Ia] in Providencia stuartii by an interaction of AarP with the promoter region.

Authors:  D R Macinga; M R Paradise; M M Parojcic; P N Rather
Journal:  Antimicrob Agents Chemother       Date:  1999-07       Impact factor: 5.191

2.  Proteobactin and a yersiniabactin-related siderophore mediate iron acquisition in Proteus mirabilis.

Authors:  Stephanie D Himpsl; Melanie M Pearson; Carl J Arewång; Tyler D Nusca; David H Sherman; Harry L T Mobley
Journal:  Mol Microbiol       Date:  2010-10       Impact factor: 3.501

Review 3.  Asymptomatic bacteriuria: when the treatment is worse than the disease.

Authors:  Barbara W Trautner
Journal:  Nat Rev Urol       Date:  2011-12-06       Impact factor: 14.432

Review 4.  Catheter-associated infections: pathogenesis affects prevention.

Authors:  Barbara W Trautner; Rabih O Darouiche
Journal:  Arch Intern Med       Date:  2004-04-26

5.  Increased incidence of urolithiasis and bacteremia during Proteus mirabilis and Providencia stuartii coinfection due to synergistic induction of urease activity.

Authors:  Chelsie E Armbruster; Sara N Smith; Alejandra Yep; Harry L T Mobley
Journal:  J Infect Dis       Date:  2013-11-26       Impact factor: 5.226

6.  Development of an intranasal vaccine to prevent urinary tract infection by Proteus mirabilis.

Authors:  Xin Li; C Virginia Lockatell; David E Johnson; M Chelsea Lane; John W Warren; Harry L T Mobley
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

7.  Single-step purification of Proteus mirabilis urease accessory protein UreE, a protein with a naturally occurring histidine tail, by nickel chelate affinity chromatography.

Authors:  B Sriwanthana; M D Island; D Maneval; H L Mobley
Journal:  J Bacteriol       Date:  1994-11       Impact factor: 3.490

8.  Genomic analysis of a pathogenicity island in uropathogenic Escherichia coli CFT073: distribution of homologous sequences among isolates from patients with pyelonephritis, cystitis, and Catheter-associated bacteriuria and from fecal samples.

Authors:  D M Guyer; J S Kao; H L Mobley
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

9.  Internalization of Proteus mirabilis by human renal epithelial cells.

Authors:  G R Chippendale; J W Warren; A L Trifillis; H L Mobley
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

10.  Genetic and biochemical diversity of ureases of Proteus, Providencia, and Morganella species isolated from urinary tract infection.

Authors:  B D Jones; H L Mobley
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.